Holocene Advisors
CNTA

Holocene Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History

Holocene Advisors’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.39M Buy
160,942
+59,345
+58% +$1.52M 0.02% 362
2025
Q4 		$2.54M Buy
+101,597
New +$2.57M 0.01% 468
2025
Q2 		– Sell
-2,255,679
Closed -$32.4M – 774
2025
Q1 		$32.4M Buy
+2,255,679
New +$36.9M 0.09% 203

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Holocene Advisors's CNTA Position: Q1 2026 in Review

Holocene Advisors increased its Centessa Pharmaceuticals (CNTA) stake by 58% in Q1 2026, buying an estimated $1.52M and bringing the position to 160,942 shares worth $6.39M. The position accounts for 0.02% of the portfolio, ranked #362.

Holocene Advisors first reported a position in CNTA in Q1 2025 and has held it in 3 quarters since. The position peaked at $32.4M in Q1 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Holocene Advisors held 160,942 shares of Centessa Pharmaceuticals worth $6.39M as of Q1 2026.
  • Holocene Advisors bought 59,345 Centessa Pharmaceuticals shares in Q1 2026, an estimated $1.52M.
  • Centessa Pharmaceuticals made up 0.02% of Holocene Advisors's portfolio in Q1 2026, its #362 holding.
  • Holocene Advisors first reported a position in Centessa Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • Holocene Advisors's Centessa Pharmaceuticals position peaked at $32.4M in Q1 2025.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.